Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
3.050
-0.110 (-3.48%)
At close: Mar 13, 2026, 4:00 PM EDT
3.070
+0.020 (0.66%)
After-hours: Mar 13, 2026, 4:10 PM EDT

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2015
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '15
Diagnostic Kits / Equipment
52.55M45.56M48.30M41.98M40.39M
Diagnostic Kits / Equipment Growth
15.33%-5.66%15.07%3.93%24.50%
Total
52.55M45.56M48.30M41.98M40.39M
Total Growth
15.33%-5.66%15.07%3.93%24.50%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2015
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '15
United States
52.55M45.56M48.30M41.98M40.39M
United States Growth
15.33%-5.66%15.07%3.93%24.50%
Total
52.55M45.56M48.30M41.98M40.39M
Total Growth
15.33%-5.66%15.07%3.93%24.50%
Source: S&P Global Market Intelligence.